Well ARDX could lower the price per gm to match what they charge for IBRSELA ..it's the same drug Teanapour . They just charge almost twice as much ...for the same drug ..to dialysis patients . Why ? Well I'm sure they will offer some BS argument for why dialysis patients must pay more than IBSC patients ...for the same drug.
Real challenge for Xphazoh MAY be the data for UNCY due this qt . If the UNCY trial shows patients will tolerate OLC ..1 small pill swallowed with meals ....and the price is less then X ...????